Vir Biotechnology EVP Eisner sells $57k in stock
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc stock price live, this page displays NASDAQ VIR stock exchange data. View the VIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vir Biotechnology Inc real time stock price chart below.
What Is the Vir Biotechnology Inc Stock Price Today?
The Vir Biotechnology Inc stock price today is 5.84.
What Is the Stock Symbol for Vir Biotechnology Inc?
The stock symbol for Vir Biotechnology Inc is ""VIR.""
What Stock Exchange Does Vir Biotechnology Inc Trade On?
Vir Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Vir Biotechnology Inc a Good Stock to Buy?
Determining whether Vir Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIR quote. (ISIN: US92764N1028)
What Is the Vir Biotechnology Inc Stock Price Today?
The Vir Biotechnology Inc stock price today is 5.84.
What Is the Stock Symbol for Vir Biotechnology Inc?
The stock symbol for Vir Biotechnology Inc is ""VIR.""
What Stock Exchange Does Vir Biotechnology Inc Trade On?
Vir Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Vir Biotechnology Inc a Good Stock to Buy?
Determining whether Vir Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIR quote. (ISIN: US92764N1028)
5.84
+0.11(+1.92%)
Real-time Data·
Fair Value
An estimate of a Vir Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.66
5.90
52 wk Range
4.32
14.45
VIR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 14 days
More Info
Fair Value
An estimate of a Vir Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.665.90
52 wk Range
4.3214.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VIR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vir Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
17.63
Upside
+201.80%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Vir Biotechnology Inc Company Profile
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company’s preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Vir Biotechnology Inc SWOT Analysis
Hepatitis Breakthrough | Vir Biotechnology's promising Phase 2 results in chronic hepatitis delta and B treatments position it as a potential market leader in addressing unmet medical needs |
Financial Crossroads | Despite a strong cash position, Vir faces challenges with negative EBITDA and EPS estimates, balancing R&D investments against the path to profitability |
Pipeline Potential | Explore Vir's diverse portfolio, including viral hepatitis programs and T-cell engagers, with peak revenue estimates exceeding $10 billion annually |
Market Valuation | Analyst price targets range from $10 to $110 per share, reflecting varied perspectives on Vir's growth potential amid clinical advancements and market opportunities |
Vir Biotechnology Inc Earnings Call Summary for Q1/2025
- Q1 2025 EPS at -$0.88, slightly missing forecast; revenue at $3.03M, significantly below $13.65M projection
- R&D expenses increased to $118.6M from $100.1M YoY; net loss widened to $121M from $65.3M in Q1 2024
- Stock declined 2.67% after-hours to $5.46; analysts set price targets from $14 to $110
- Company focuses on ECLIPSE Phase 3 trials for Hepatitis Delta and advancing oncology programs
- CEO emphasizes operational excellence; CMO highlights potential of dual-masked T cell engager technology
Last Updated: 07/05/2025, 22:36
Read Full TranscriptCompare VIR to Peers and Sector
Metrics to compare | VIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −4.4x | −0.5x | |
PEG Ratio | 0.26 | −0.16 | 0.00 | |
Price/Book | 0.8x | 2.8x | 2.6x | |
Price / LTM Sales | 38.0x | 10.0x | 3.2x | |
Upside (Analyst Target) | 170.5% | 116.9% | 42.7% | |
Fair Value Upside | Unlock | 16.8% | 5.8% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 17.63
(+201.80% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
-0.88 / -0.87
Revenue / Forecast
3.03M / 13.65M
People Also Watch
FAQ
What Stock Exchange Does Vir Biotech Trade On?
Vir Biotech is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Vir Biotech?
The stock symbol for Vir Biotech is "VIR."
What Is the Vir Biotech Market Cap?
As of today, Vir Biotech market cap is 804.55M.
What Is Vir Biotech's Earnings Per Share (TTM)?
The Vir Biotech EPS (TTM) is -4.22.
When Is the Next Vir Biotech Earnings Date?
Vir Biotech will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is VIR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Vir Biotech Stock Split?
Vir Biotech has split 0 times.
How Many Employees Does Vir Biotech Have?
Vir Biotech has 408 employees.
What is the current trading status of Vir Biotech (VIR)?
As of 23 Jul 2025, Vir Biotech (VIR) is trading at a price of 5.84, with a previous close of 5.73. The stock has fluctuated within a day range of 5.66 to 5.90, while its 52-week range spans from 4.32 to 14.45.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.